What is the address of Dr. Luc Van Driessche Cardiologie?

The registered office of Dr. Luc Van Driessche Cardiologie is located at Schoolstraat 34, 9160 Lokeren.

Is Dr. Luc Van Driessche Cardiologie still active?

Yes. According to the CBE (1 October 2026) Dr. Luc Van Driessche Cardiologie is active, legal situation “Normale toestand”, started on 2 April 2008.

Is Dr. Luc Van Driessche Cardiologie registered on Peppol?

No, Dr. Luc Van Driessche Cardiologie is currently not registered on the Peppol network.

What is the enterprise number of Dr. Luc Van Driessche Cardiologie?

The enterprise number of Dr. Luc Van Driessche Cardiologie is BE0896886348.

When was Dr. Luc Van Driessche Cardiologie founded?

Dr. Luc Van Driessche Cardiologie was founded on 2 April 2008.

Who are the directors of Dr. Luc Van Driessche Cardiologie?

According to the 2025 annual accounts, the directors of Dr. Luc Van Driessche Cardiologie are: Luc Van Driessche.

Is Dr. Luc Van Driessche Cardiologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 April 2008; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Luc Van Driessche Cardiologie make in 2025?

Dr. Luc Van Driessche Cardiologie posted a profit after taxes of € 319,183 in financial year 2025.

What is the revenue of Dr. Luc Van Driessche Cardiologie?

As a small company, Dr. Luc Van Driessche Cardiologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 469,826.

Dr. Luc Van Driessche Cardiologie (Private Limited)

Dossier Dr. Luc Van Driessche Cardiologie, printed on 1 October 2026 from databakkes.be/en/0896886348/dr-luc-van-driessche-cardiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Dr. Luc Van Driessche Cardiologie from Lokeren, company number BE0896886348, closed financial year 2025 with a result of € 319,183 after tax. For that financial year Dr. Luc Van Driessche Cardiologie recorded a gross margin of € 469,826 and equity of € 1.8 million. Compared with financial year 2024, the result moved from € 308,754 to € 319,183. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.

What it is worth Growing

€ 1.8 million

▲ 6% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 319,183

▲ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 413,323

▼ 39% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 210,243 paid out

66 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 43,660

▼ 33% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,302

▲ 47% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 46,735

▼ 36% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 535,046 Gross margin 2022: € 535,046 First fiscal year in the series	€ 550,807 Gross margin 2023: € 550,807 ▲ 3% vs 2022 (€ 535,046) Favourable step	€ 458,307 Gross margin 2024: € 458,307 ▼ 17% vs 2023 (€ 550,807) Unfavourable step	€ 469,826 Gross margin 2025: € 469,826 ▲ 3% vs 2024 (€ 458,307) Favourable step	▲ 3%
Profit after taxes	€ 354,921 Profit after taxes 2022: € 354,921 First fiscal year in the series	€ 359,577 Profit after taxes 2023: € 359,577 ▲ 1% vs 2022 (€ 354,921) Favourable step	€ 308,754 Profit after taxes 2024: € 308,754 ▼ 14% vs 2023 (€ 359,577) Unfavourable step	€ 319,183 Profit after taxes 2025: € 319,183 ▲ 3% vs 2024 (€ 308,754) Favourable step	▲ 3%
Equity	€ 1,497,571 Equity 2022: € 1,497,571 First fiscal year in the series	€ 1,857,148 Equity 2023: € 1,857,148 ▲ 24% vs 2022 (€ 1,497,571) Favourable step	€ 1,722,278 Equity 2024: € 1,722,278 ▼ 7% vs 2023 (€ 1,857,148) Unfavourable step	€ 1,831,218 Equity 2025: € 1,831,218 ▲ 6% vs 2024 (€ 1,722,278) Favourable step	▲ 6%
Total debts	€ 188,962 Total debts 2022: € 188,962 First fiscal year in the series	€ 95,620 Total debts 2023: € 95,620 ▼ 49% vs 2022 (€ 188,962) Favourable step	€ 92,236 Total debts 2024: € 92,236 ▼ 4% vs 2023 (€ 95,620) Favourable step	€ 51,037 Total debts 2025: € 51,037 ▼ 45% vs 2024 (€ 92,236) Favourable step	▼ 45%
Cash	€ 1,321,723 Cash 2022: € 1,321,723 First fiscal year in the series	€ 806,665 Cash 2023: € 806,665 ▼ 39% vs 2022 (€ 1,321,723) Unfavourable step	€ 679,675 Cash 2024: € 679,675 ▼ 16% vs 2023 (€ 806,665) Unfavourable step	€ 413,323 Cash 2025: € 413,323 ▼ 39% vs 2024 (€ 679,675) Unfavourable step	▼ 39%
Retained profit	€ 1,485,171 Retained profit 2022: € 1,485,171 First fiscal year in the series	€ 1,844,748 Retained profit 2023: € 1,844,748 ▲ 24% vs 2022 (€ 1,485,171) Favourable step	€ 1,709,878 Retained profit 2024: € 1,709,878 ▼ 7% vs 2023 (€ 1,844,748) Unfavourable step	€ 1,818,818 Retained profit 2025: € 1,818,818 ▲ 6% vs 2024 (€ 1,709,878) Favourable step	▲ 6%
Dividend	€ 220,972 Dividend 2022: € 220,972 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 220,972) Unchanged	€ 443,623 Dividend 2024: € 443,623 Unchanged (€ 0) Unchanged	€ 210,243 Dividend 2025: € 210,243 ▼ 53% vs 2024 (€ 443,623) Unchanged	▼ 53%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 369 Bank debt 2024: € 369 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 369) Favourable step	▼ 100%
Balance sheet total	€ 1,686,533 Balance sheet total 2022: € 1,686,533 First fiscal year in the series	€ 1,952,768 Balance sheet total 2023: € 1,952,768 ▲ 16% vs 2022 (€ 1,686,533) Unchanged	€ 1,814,514 Balance sheet total 2024: € 1,814,514 ▼ 7% vs 2023 (€ 1,952,768) Unchanged	€ 1,882,255 Balance sheet total 2025: € 1,882,255 ▲ 4% vs 2024 (€ 1,814,514) Unchanged	▲ 4%

Key figures of Dr. Luc Van Driessche Cardiologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Luc Van Driessche Cardiologie?

What happened at Dr. Luc Van Driessche Cardiologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 27, 2026 New annual accounts for financial year 2025: profit of € 319,183 (▲ 3% vs 2024). Source: NBB ↗
Apr 2, 2008 New establishment in Lokeren. KBO
Apr 2, 2008 Start of the company according to the CBE. KBO
2008 Luc Van Driessche became a director. NBB

In short

From € 354,921 profit in 2022 to € 319,183 profit in 2025.

Paid € 600,476 in corporate taxes since 2022.

Best year ever: 2023, with € 359,577 profit.

Paid out € 874,838 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Luc Van Driessche Cardiologie? We notify you, reason included.

Follow Dr. Luc Van Driessche Cardiologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Luc Van Driessche

Dr. Luc Van Driessche Cardiologie

Behind Dr. Luc Van Driessche Cardiologie is Luc Van Driessche.

See the full network in the app

Directors

According to the 2025 annual accounts

Luc Van Driessche

Director

since 2008

Establishments

Establishment units

Physical locations of this company

Registered office

Schoolstraat 34

9160 Lokeren

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0896.886.348
VAT number: BE 0896.886.348
Registered office: Schoolstraat 34, 9160 Lokeren
Names & denominations: Dr. Luc Van Driessche Cardiologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 2 April 2008
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗